Connect your AI

OMDA OMDA Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

Tandem Diabetes CareTNDM

——

AdaptHealthAHCO

——

Opko HealthOPK

——

Other financials

Income statement

Revenue$78.0M+42.0%

Gross profit$48.7M+52.6%

Operating income-$4.8M+43.1%

Net income-$3.0M+68.6%

EPS (diluted)-$0.05+95.7%

Balance sheet

Cash & equivalents$211.8M+257%

Total debt$30.0M—

Total equity$234.1M+160%

Total assets$302.8M—

Cash flow

Operating cash flow-$11.8M+26.6%

CapEx$78.0K-75.2%

Free cash flow-$11.9M+27.5%

Valuation

Market cap$1.11B+23.8%

P/S3.9×-0.4×

Profitability

Gross margin66.3%+4.4pp

Operating margin-9.6%-4.0pp

Net margin-11.3%-4.6pp

FCF margin-40.8%—

Returns & leverage

Return on equity26.8%—

Debt / equity0.1×—

Current ratio3.9×—

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OMDA's amortization expense related to capitalized debt issuance costs?: OMDA (OMDA) reported amortization expense related to capitalized debt issuance costs of $0 in Q1 2026.
How has OMDA's amortization expense related to capitalized debt issuance costs changed year-over-year?: OMDA's amortization expense related to capitalized debt issuance costs decreased by 100.0% year-over-year, from $109K to $0.